John B. Sanfilippo & Son
JBSS
67.95
+0.19
+0.28%
John B. Sanfilippo & Son
US · JBSS
#3422 by market cap
67.95
+0.19
+0.28%
Live - 5344 symbols - heartbeat 272s ago
· 2026-10-08 07:58
Pre-market
67.95
0.00%
After-hours
67.95
0.00%
- Market cap
- 794.57M
- P/E (TTM)i
- 12.92
- P/Bi
- 2.09
- EPSi
- 5.26
- Div yieldi
- 1.32%
- 52W posi
- 35%
Reader sentiment
Are you bullish or bearish on JBSS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.77, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +6.18% YoY
Margins
- Gross margin
- 17.96%
- Operating margin
- 7.40%
- Net margin
- 5.27%
Key ratios & quality
- Enterprise valuei
- 876.90M
- Altman Z-Scorei
- 4.77
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 876.20M | 880.09M | 858.48M | 955.87M | 999.69M | 1.07B | 1.11B | 1.18B |
| Gross profit | 158.27M | 175.78M | 184.99M | 199.63M | 211.63M | 214.14M | 203.47M | 211.18M |
| Selling & admin expenses | 100.84M | 98.79M | 101.21M | 115.89M | 122.73M | 132.48M | 120.61M | 124.22M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 57.44M | 76.98M | 83.78M | 83.74M | 88.90M | 81.66M | 82.86M | 86.96M |
| Pretax profit | 52.43M | 72.71M | 79.82M | 81.70M | 85.35M | 79.94M | 77.87M | 82.98M |
| Tax | 12.96M | 18.60M | 20.08M | 19.91M | 22.49M | 19.69M | 18.93M | 21.04M |
| Net profit | 39.47M | 54.11M | 59.74M | 61.79M | 62.86M | 60.25M | 58.93M | 61.93M |
| Basic EPS | 3 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Diluted EPS | 3.43 | 4.69 | 5.17 | 5.33 | 5.40 | 5.15 | 5.03 | 5.26 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 260.91M | 269.08M | 298.68M | 314.78M | 281.78M | 280.43M |
| Gross profit | 55.89M | 48.78M | 54.09M | 59.17M | 53.77M | 44.15M |
| Selling & admin expenses | 28.33M | 29.10M | 27.65M | 33.77M | 30.56M | 32.24M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 27.56M | 19.69M | 26.44M | 25.40M | 23.21M | 11.91M |
| Pretax profit | 26.14M | 18.12M | 25.07M | 24.51M | 22.30M | 11.10M |
| Tax | 5.99M | 4.59M | 6.34M | 6.55M | 5.45M | 2.70M |
| Net profit | 20.15M | 13.53M | 18.73M | 17.96M | 16.85M | 8.40M |
| Basic EPS | 2 | 1 | 2 | 2 | 1 | 1 |
| Diluted EPS | 1.72 | 1.15 | 1.59 | 1.53 | 1.43 | 0.71 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 225.34M | 238.87M | 225.17M | 283.16M | 254.43M | 294.09M | 346.42M | 349.31M |
| Cash & ST investments | 1.59M | 1.54M | 672.00K | 415.00K | 1.95M | 484.00K | 585.00K | 1.15M |
| Inventory | 157.02M | 172.07M | 148.00M | 204.86M | 172.94M | 196.56M | 254.60M | 245.83M |
| Total assets | 391.30M | 407.46M | 398.46M | 447.26M | 425.29M | 515.58M | 597.60M | 658.58M |
| Total current liabilities | 83.91M | 112.17M | 100.20M | 122.76M | 85.69M | 125.94M | 156.05M | 167.93M |
| Short-term debt | 8.24M | 34.33M | 13.62M | 43.80M | 957.00K | 21.70M | 58.82M | 39.90M |
| Long-term debt | 20.38M | 14.73M | 10.86M | 7.77M | 7.10M | 6.37M | 14.56M | 43.57M |
| Total liabilities | 136,749,000.00 | 169,219,000.00 | 155,961,000.00 | 168,441,000.00 | 133,080,000.00 | 192,962,000.00 | 236,906,000.00 | 278,633,000.00 |
| Total equity | 254.56M | 238.24M | 242.49M | 278.82M | 292.21M | 322.61M | 360.70M | 379.95M |
| Retained earnings | 137.71M | 124.06M | 126.34M | 153.59M | 161.51M | 186.97M | 221.50M | 236.67M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 349.20M | 346.42M | 333.52M | 337.22M | 352.14M | 349.31M |
| Cash & ST investments | 1.30M | 585.00K | 714.00K | 2.40M | 1.29M | 1.15M |
| Inventory | 257.80M | 254.60M | 234.72M | 235.43M | 252.62M | 245.83M |
| Total assets | 589.98M | 597.60M | 598.68M | 617.73M | 650.67M | 658.58M |
| Total current liabilities | 173.99M | 156.05M | 136.67M | 148.41M | 153.17M | 167.93M |
| Short-term debt | 91.33M | 58.82M | 54.00M | 15.89M | 35.71M | 39.90M |
| Long-term debt | 5.77M | 14.56M | 29.83M | 28.84M | 40.67M | 43.57M |
| Total liabilities | 243,363,000.00 | 236,906,000.00 | 235,898,000.00 | 247,605,000.00 | 263,020,000.00 | 278,633,000.00 |
| Total equity | 346.61M | 360.70M | 362.78M | 370.12M | 387.65M | 379.95M |
| Retained earnings | 207.97M | 221.50M | 222.73M | 228.98M | 245.83M | 236.67M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 83.46M | 63.61M | 104.70M | 19.60M | 124.66M | 101.67M | 30.55M | 123.84M |
| Depreciation & amortization | 17.05M | 17.93M | 18.31M | 19.71M | 22.14M | 26.60M | 31.47M | 33.30M |
| Free cash flow | 68.38M | 48.59M | 79.52M | 1.85M | 103.92M | 73.36M | -20.17M | 35.75M |
| Dividends paid | -29.07M | -68.74M | -57.46M | -34.53M | -54.93M | -34.80M | -24.40M | -46.76M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 1.59M | 1.54M | 672.00K | 415.00K | 1.95M | 484.00K | 585.00K | 1.15M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -25.90M | 36.53M | 32.13M | 62.49M | 197.00K | 29.02M |
| Depreciation & amortization | 7.90M | 8.23M | 8.37M | 8.29M | 8.34M | 8.31M |
| Free cash flow | -37.58M | 23.05M | 7.26M | 40.05M | -21.47M | 9.91M |
| Dividends paid | 0 | 0 | -17.49M | 0 | -11.70M | -17.56M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 1.30M | 585.00K | 714.00K | 2.40M | 1.29M | 1.15M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 15.87 | 21.96 | 24.85 | 23.70 | 22.02 | 19.60 | 17.25 | 16.72 |
| ROA %i | 9.78 | 13.55 | 14.83 | 14.61 | 14.41 | 12.81 | 10.59 | 9.86 |
| ROIC %i | 14.06 | 19.39 | 21.75 | 21.06 | 20.25 | 18.27 | 14.78 | 13.53 |
| 5-year avg ROE %i | 13.83 | 15.72 | 18.22 | 19.99 | 21.68 | 22.43 | 21.48 | 19.86 |
| EBIT margin %i | 6.33 | 8.49 | 9.47 | 8.75 | 8.75 | 7.73 | 7.35 | 7.26 |
| FCF / sales %i | 7.80 | 5.52 | 9.26 | 0.19 | 10.40 | 6.88 | -- | 3.04 |
| Current ratioi | 2.69 | 2.13 | 2.25 | 2.31 | 2.97 | 2.34 | 2.22 | 2.08 |
| Quick ratioi | 0.75 | 0.52 | 0.67 | 0.57 | 0.87 | 0.68 | 0.49 | 0.51 |
| Debt / assetsi | 7.31 | 12.78 | 6.67 | 11.77 | 3.02 | 10.27 | 16.33 | 15.81 |
| LT debt / equityi | 8.01 | 7.44 | 5.34 | 3.17 | 4.06 | 9.68 | 10.75 | 16.90 |
| Interest coveragei | 18.13 | 37.26 | 56.39 | 43.53 | 40.53 | 32.36 | 22.92 | 35.16 |
| Revenue CAGR (3Y) %i | -2.73 | 1.30 | -1.16 | 2.94 | 4.34 | 7.51 | 5.02 | 5.55 |
| Net income CAGR (3Y) %i | 9.10 | 14.42 | 22.50 | 16.12 | 5.12 | 0.28 | -1.56 | -0.49 |
| FCF CAGR (3Y) %i | -2.70 | 5.16 | 14.54 | -69.98 | 28.84 | -2.65 | -- | -29.93 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 16.58 | 17.25 | 19.60 | 20.23 | 18.27 | 16.72 |
| ROA %i | 10.24 | 10.59 | 11.81 | 12.10 | 10.81 | 9.86 |
| ROIC %i | 13.75 | 14.78 | 16.03 | 17.26 | 14.55 | 13.53 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.86 | 7.35 | 8.08 | 8.53 | 8.01 | 7.26 |
| FCF / sales %i | -- | -- | -- | 2.87 | 4.20 | 3.04 |
| Current ratioi | 2.01 | 2.22 | 2.44 | 2.27 | 2.30 | 2.08 |
| Quick ratioi | 0.44 | 0.49 | 0.62 | 0.55 | 0.56 | 0.51 |
| Debt / assetsi | 20.75 | 16.33 | 17.93 | 10.99 | 15.11 | 15.81 |
| LT debt / equityi | 8.96 | 10.75 | 14.70 | 14.04 | 16.15 | 16.90 |
| Interest coveragei | 26.92 | 22.92 | 22.70 | 26.02 | 28.96 | 35.16 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Trail & Snack Mixes is the largest reported line at 23.60% of revenue, across 8 reported segments.
- No single line clears half of revenue; Cashews & Mixed Nuts is next at 18.80%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Trail & Snack Mixes23.60%
Cashews & Mixed Nuts18.80%
Peanuts & Peanut Butter15.50%
Bars12.50%
Pecans9.60%
Almonds7.50%
Walnuts6.80%
Other5.70%
Region
United States100.00%
Quote time 2026-10-08 07:58:36 · For reference only, not investment advice and not tailored to your situation.